Christopher P. Childers
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Christopher P. Childers has a total of 103 co-authors. Here are the top co-authors by number of shared publications:
Melinda Maggard-Gibbons
Ronald Reagan UCLA Medical Center, Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California
22 shared publicationsJill Q. Dworsky
Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA
7 shared publicationsKimberly K. Childers
Center for Clinical Genetics and Genomics, Providence St. Joseph Health, Los Angeles, California
4 shared publicationsMarcia M. Russell
Department of Surgery, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles
4 shared publicationsMelinda A. Maggard Gibbons
University of California-Los Angeles, Los Angeles, CA
4 shared publicationsMelinda Md Maggard-Gibbons
Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA
3 shared publications
Latest Publications
- Open Access
- 18 September 2026
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
Trends in Medicare Work Relative Value Unit Payment Rates Across Physician Specialties: 2018-2024
Background: Recent Medicare Physician Fee Schedule revisions have sought to narrow perceived compensation differences between medical and surgical specialties, but their effects on work relative value unit (wRVU) payment rates are unknown. We estimated contemporary specialty-level wRVU payment rates and trends from 2018 through 2024. Study Design: Repeated cross-sectional analysis of Medicare Part B fee-for-service claims linked CMS Physician Time File, Addendum B, and Physician/Supplier Procedure Summary Master File data at the CPT–specialty–year level across 42 specialties (27 medical, 15 surgical). The primary outcome was annual specialty-level wRVU payment rate (wRVUs/min). Linear regression quantified trajectories. A counterfactual holding service times at 2018 values estimated rates assuming constant service times. Results: The medical–surgical payment-rate gap narrowed from 5.4% in 2018 (0.0405 vs 0.0426 wRVUs/min; P=.051) to 1.6% in 2024 (0.0428 vs 0.0435; P=.26), with convergence concentrated in 2021 and 2023, coinciding with evaluation and management revaluations. Primary care (+1.7%/year; P=.009) and nonsurgical nonprocedural specialties (+1.8%/year; P=.006) increased faster than surgical specialties (+0.4%/year). Under the counterfactual, 2024 rates exceeded actual values by 8.9% for primary care, 6.9% for nonsurgical nonprocedural, 5.0% for nonsurgical procedural, 4.5% for surgical, and 0.1% for facility-based specialties, narrowing the medical–surgical gap to 0.8%. Conclusions: From 2018 through 2024, the Medicare medical–surgical wRVU payment-rate gap narrowed from 5.4% to 1.6% under current CMS valuation assumptions. These findings suggest the Medicare Physician Fee Schedule may be a limited instrument for narrowing broader specialty compensation differences.
- 18 September 2026
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
Open AccessTrends in Medicare Work Relative Value Unit Payment Rates Across Physician Specialties: 2018-2024
Background: Recent Medicare Physician Fee Schedule revisions have sought to narrow perceived compensation differences between medical and surgical specialties, but their effects on work relative value unit (wRVU) payment rates are unknown. We estimated contemporary specialty-level wRVU payment rates and trends from 2018 through 2024. Study Design: Repeated cross-sectional analysis of Medicare Part B fee-for-service claims linked CMS Physician Time File, Addendum B, and Physician/Supplier Procedure Summary Master File data at the CPT–specialty–year level across 42 specialties (27 medical, 15 surgical). The primary outcome was annual specialty-level wRVU payment rate (wRVUs/min). Linear regression quantified trajectories. A counterfactual holding service times at 2018 values estimated rates assuming constant service times. Results: The medical–surgical payment-rate gap narrowed from 5.4% in 2018 (0.0405 vs 0.0426 wRVUs/min; P=.051) to 1.6% in 2024 (0.0428 vs 0.0435; P=.26), with convergence concentrated in 2021 and 2023, coinciding with evaluation and management revaluations. Primary care (+1.7%/year; P=.009) and nonsurgical nonprocedural specialties (+1.8%/year; P=.006) increased faster than surgical specialties (+0.4%/year). Under the counterfactual, 2024 rates exceeded actual values by 8.9% for primary care, 6.9% for nonsurgical nonprocedural, 5.0% for nonsurgical procedural, 4.5% for surgical, and 0.1% for facility-based specialties, narrowing the medical–surgical gap to 0.8%. Conclusions: From 2018 through 2024, the Medicare medical–surgical wRVU payment-rate gap narrowed from 5.4% to 1.6% under current CMS valuation assumptions. These findings suggest the Medicare Physician Fee Schedule may be a limited instrument for narrowing broader specialty compensation differences.
- 13 July 2026
- Published by Springer Nature in Annals of Surgical Oncology
A National Survey of Contracts, Compensation, and Workplace Culture Among Junior Surgical Oncologists.
The transition from surgical training to independent practice is challenging, and little quantitative data exist to guide junior surgeons on contracts and compensation. Qualitative evidence suggests compensation model type may influence workplace dynamics and attrition, but this has not been formally examined. A cross-sectional survey of Society of Surgical Oncology members in their first 8 years of practice was conducted in October-November 2025 (n = 221; response rate = 20.2%). Outcomes included contract and compensation characteristics, attrition risk, and workplace collegiality. Respondents were 53% female, 68% non-Hispanic white, and 65% academic; 40% were within their first 2 years of practice. Most (69%) attempted contract negotiation and 79% succeeded in at least one domain. Nearly all (79%) had a guaranteed salary period (median 3 years), after which most transitioned to work relative value unit (wRVU)-based compensation. One in four respondents (25%) were considering leaving within the year; this rose to nearly 80% among those who strongly disagreed their compensation was fair (p < 0.01). Greater productivity emphasis was inversely associated with workplace collegiality (odds ratio 1.8 per standard deviation [SD] increase, 95% confidence interval [CI] 1.1-3.0; p = 0.02). This national survey provides contract and compensation data for junior surgical oncologists and demonstrates associations between perceived compensation fairness and attrition risk, and between productivity-based compensation emphasis and workplace hostility. These findings suggest that how surgeons perceive their compensation-not merely its structure-may be a target for institutional efforts to improve retention and culture.
- 13 July 2026
- Published by Springer Nature in Annals of Surgical Oncology
A National Survey of Contracts, Compensation, and Workplace Culture Among Junior Surgical Oncologists.
The transition from surgical training to independent practice is challenging, and little quantitative data exist to guide junior surgeons on contracts and compensation. Qualitative evidence suggests compensation model type may influence workplace dynamics and attrition, but this has not been formally examined. A cross-sectional survey of Society of Surgical Oncology members in their first 8 years of practice was conducted in October-November 2025 (n = 221; response rate = 20.2%). Outcomes included contract and compensation characteristics, attrition risk, and workplace collegiality. Respondents were 53% female, 68% non-Hispanic white, and 65% academic; 40% were within their first 2 years of practice. Most (69%) attempted contract negotiation and 79% succeeded in at least one domain. Nearly all (79%) had a guaranteed salary period (median 3 years), after which most transitioned to work relative value unit (wRVU)-based compensation. One in four respondents (25%) were considering leaving within the year; this rose to nearly 80% among those who strongly disagreed their compensation was fair (p < 0.01). Greater productivity emphasis was inversely associated with workplace collegiality (odds ratio 1.8 per standard deviation [SD] increase, 95% confidence interval [CI] 1.1-3.0; p = 0.02). This national survey provides contract and compensation data for junior surgical oncologists and demonstrates associations between perceived compensation fairness and attrition risk, and between productivity-based compensation emphasis and workplace hostility. These findings suggest that how surgeons perceive their compensation-not merely its structure-may be a target for institutional efforts to improve retention and culture.
- 14 August 2025
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 241 (3) , 357-363
Obesity and Work in Abdominal Surgery
BACKGROUND: Recent analyses have shown that Modifier 22 does not reimburse surgeons for the increased work required to care for the most complex patients. New strategies are needed to identify patients who require additional work to create a financial system that ensures equitable access. Obesity has been identified as a growing and potentially reliable patient risk factor that could be used to identify cases that require additional work. STUDY DESIGN: Using 2022 American College of Surgeons NSQIP data, this study evaluated 10 common general surgery operations (appendectomy, cholecystectomy, colon/rectal operations, hernia repairs). The primary predictor was BMI category (normal: 18.5 to 25 kg/m2, overweight: 25 to 29.9 kg/m2, class I obesity: 30 to 34.9 kg/m2, class II obesity: 35 to 39.9 kg/m2, class III obesity 40 to 49.9 kg/m2, extreme obesity 50 kg/m2 or more). Primary outcomes were operative time and composite measures of complications. RESULTS: The final sample included 158,692 operations. Across the entire cohort, 22.2% were normal weight and 76.3% were overweight or obese. Overall, operative time was increased by 5.6% (95% CI 4.8% to 6.3%) for overweight, by 10.6% (95% CI 9.8% to 11.5%) for class I obesity, by 14.7% (95% CI 13.6% to 15.8%) for class II obesity, by 18.9% (95% CI 17.6% to 20.2%) for class III obesity, and by 26.8% (95% CI 14.1% to 29.6%) for extreme obesity compared with those with normal BMI. Obesity was associated with higher odds of any complication or serious complication, driven by wound complications, pulmonary emboli, and renal insufficiency. CONCLUSIONS: Obesity is a growing challenge in abdominal surgery and is associated with an increase in operative time and risk of complications. The consistency of the magnitude of effect makes it an ideal target for a modifier or add-on code that could identify cases requiring additional work.
- 14 August 2025
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 241 (3) , 357-363
Obesity and Work in Abdominal Surgery
BACKGROUND: Recent analyses have shown that Modifier 22 does not reimburse surgeons for the increased work required to care for the most complex patients. New strategies are needed to identify patients who require additional work to create a financial system that ensures equitable access. Obesity has been identified as a growing and potentially reliable patient risk factor that could be used to identify cases that require additional work. STUDY DESIGN: Using 2022 American College of Surgeons NSQIP data, this study evaluated 10 common general surgery operations (appendectomy, cholecystectomy, colon/rectal operations, hernia repairs). The primary predictor was BMI category (normal: 18.5 to 25 kg/m2, overweight: 25 to 29.9 kg/m2, class I obesity: 30 to 34.9 kg/m2, class II obesity: 35 to 39.9 kg/m2, class III obesity 40 to 49.9 kg/m2, extreme obesity 50 kg/m2 or more). Primary outcomes were operative time and composite measures of complications. RESULTS: The final sample included 158,692 operations. Across the entire cohort, 22.2% were normal weight and 76.3% were overweight or obese. Overall, operative time was increased by 5.6% (95% CI 4.8% to 6.3%) for overweight, by 10.6% (95% CI 9.8% to 11.5%) for class I obesity, by 14.7% (95% CI 13.6% to 15.8%) for class II obesity, by 18.9% (95% CI 17.6% to 20.2%) for class III obesity, and by 26.8% (95% CI 14.1% to 29.6%) for extreme obesity compared with those with normal BMI. Obesity was associated with higher odds of any complication or serious complication, driven by wound complications, pulmonary emboli, and renal insufficiency. CONCLUSIONS: Obesity is a growing challenge in abdominal surgery and is associated with an increase in operative time and risk of complications. The consistency of the magnitude of effect makes it an ideal target for a modifier or add-on code that could identify cases requiring additional work.
- Open Access
- 5 October 2024
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 31 (13) , 8479-8480
Better Outcomes or Just Bragging Rights?
- 5 October 2024
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 31 (13) , 8479-8480
Open AccessBetter Outcomes or Just Bragging Rights?
- 13 April 2023
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 30 (6) , 3569
ASO Visual Abstract: Insurance Disparities in Access to Robotic Surgery for Colorectal Cancer
- 13 April 2023
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 30 (6) , 3569
ASO Visual Abstract: Insurance Disparities in Access to Robotic Surgery for Colorectal Cancer
- 21 March 2023
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 30 (6) , 3560-3568
Insurance Disparities in Access to Robotic Surgery for Colorectal Cancer
The use of the robotic approach is increasing for colorectal cancer operations, but the added cost of the platform has the potential to introduce challenge
- 21 March 2023
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 30 (6) , 3560-3568
Insurance Disparities in Access to Robotic Surgery for Colorectal Cancer
The use of the robotic approach is increasing for colorectal cancer operations, but the added cost of the platform has the potential to introduce challenge
- 1 October 2022
- Published by American Medical Association (AMA) in JAMA Surgery
- Vol. 157 (10) , 959-960
Compliance of National Cancer Institute–Designated Cancer Centers With January 2021 Price Transparency Requirements
In an effort to increase competition and drive down prices, the Centers for Medicare & Medicaid Services (CMS) initiated 2 policies in the last 3 years to increase hospital price transparency.1 Starting January 2019, hospitals were required to publish their chargemasters—a list of the nondiscounted prices for services provided. This effort has been criticized because charges rarely reflect the actual prices paid for a service and do little to spur competition.2,3 In response to this criticism, CMS expanded this mandate in January 2021 to require hospitals to publish a list of their negotiated rates with health insurers. In theory, this should more effectively increase competition between payors and hospitals and drive down rates. Identify all potential conflicts of interest that might be relevant to your comment. Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. Err on the side of full disclosure. If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response. Not all submitted comments are published. Please see our commenting policy for details.
- 1 October 2022
- Published by American Medical Association (AMA) in JAMA Surgery
- Vol. 157 (10) , 959-960
Compliance of National Cancer Institute–Designated Cancer Centers With January 2021 Price Transparency Requirements
In an effort to increase competition and drive down prices, the Centers for Medicare & Medicaid Services (CMS) initiated 2 policies in the last 3 years to increase hospital price transparency.1 Starting January 2019, hospitals were required to publish their chargemasters—a list of the nondiscounted prices for services provided. This effort has been criticized because charges rarely reflect the actual prices paid for a service and do little to spur competition.2,3 In response to this criticism, CMS expanded this mandate in January 2021 to require hospitals to publish a list of their negotiated rates with health insurers. In theory, this should more effectively increase competition between payors and hospitals and drive down rates. Identify all potential conflicts of interest that might be relevant to your comment. Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. Err on the side of full disclosure. If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response. Not all submitted comments are published. Please see our commenting policy for details.
- 1 May 2022
- Published by American Medical Association (AMA) in JAMA Surgery
- Vol. 157 (5) , e220107
When 1 Plus 1 Equals 3—The Art, Not Science, of RVU Valuations
In this issue of JAMA Surgery, Crespin and colleagues1 report a thorough analysis using the US Centers for Medicare & Medicaid Services fee-for-service data demonstrating that assumptions of operative time used to generate relative value unit (RVU) valuations are incorrect. On average, the time assumed in RVU valuations is longer than the time actually required to perform these procedures. This finding is consistent across multiple analyses using varied data sources and should be considered a fact.2-4 But, operative time is only 1 part of the RVU puzzle. Identify all potential conflicts of interest that might be relevant to your comment. Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. Err on the side of full disclosure. If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response. Not all submitted comments are published. Please see our commenting policy for details.
- 1 May 2022
- Published by American Medical Association (AMA) in JAMA Surgery
- Vol. 157 (5) , e220107
When 1 Plus 1 Equals 3—The Art, Not Science, of RVU Valuations
In this issue of JAMA Surgery, Crespin and colleagues1 report a thorough analysis using the US Centers for Medicare & Medicaid Services fee-for-service data demonstrating that assumptions of operative time used to generate relative value unit (RVU) valuations are incorrect. On average, the time assumed in RVU valuations is longer than the time actually required to perform these procedures. This finding is consistent across multiple analyses using varied data sources and should be considered a fact.2-4 But, operative time is only 1 part of the RVU puzzle. Identify all potential conflicts of interest that might be relevant to your comment. Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. Err on the side of full disclosure. If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response. Not all submitted comments are published. Please see our commenting policy for details.
- 10 March 2022
- Published by Cambridge University Press (CUP) in The Review of Politics
- Vol. 84 (2) , 284-286
Peter Charles Hoffer: Daniel Webster and the Unfinished Constitution. (Lawrence: University Press of Kansas, 2021. Pp. viii, 195.)
Peter Charles Hoffer: Daniel Webster and the Unfinished Constitution. (Lawrence: University Press of Kansas, 2021. Pp. viii, 195.)
- 10 March 2022
- Published by Cambridge University Press (CUP) in The Review of Politics
- Vol. 84 (2) , 284-286
Peter Charles Hoffer: Daniel Webster and the Unfinished Constitution. (Lawrence: University Press of Kansas, 2021. Pp. viii, 195.)
Peter Charles Hoffer: Daniel Webster and the Unfinished Constitution. (Lawrence: University Press of Kansas, 2021. Pp. viii, 195.)